Menu

Study: Acidic Oceans Behind Extinctions

Massive die-offs of just about every marine species millions of years ago are thought to have resulted from a surge of carbon dioxide.

Apr 13, 2015
Kerry Grens

PIXABAY, PUBLICDOMAINPICTURESVolcanic eruptions 252 million years ago dumped loads of carbon dioxide into the oceans, causing acidification that led to mass extinctions globally, according to work published in Science last week (April 10).

“Scientists have long suspected that an ocean acidification event occurred during the greatest mass extinction of all time, but direct evidence has been lacking until now,” lead author Matthew Clarkson of the University of Edinburgh’s School of GeoSciences said in a press release. “This is a worrying finding, considering that we can already see an increase in ocean acidity today that is the result of human carbon emissions.”

During this extinction event, 90 percent of marine species were wiped out, along with two-thirds of terrestrial plants and animals. Scientists had proposed that volcanoes or ocean acidification could have been involved in the die-offs, but Clarkson team measured pH more directly than previous studies, according to Nature News.

By analyzing boron isotopes from Permian-era rocks in the United Arab Emirates, the researchers saw a sudden drop in pH that occurred over 10,000 years at the tail end of what’s called the Great Dying. “It’s such a rapid change, the ocean can’t buffer the CO2 increase,” Clarkson told Nature News.

“Surprisingly, the pH shift doesn’t happen during what most of us have considered the big event,” Penn State geochemist Lee Kump told Live Science. “It’s an interesting result, but it’s not conclusive. I think we need more of these sections around the world.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.